Symbol: DGX Sector: Healthcare Industry: Medical Diagnostics & Research
Update: 2019-06-09 17:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2019-03-31 |
1,891,000,000 |
1,891,000,000 |
1,244,000,000 |
647,000,000 |
399,000,000 |
248,000,000 |
164,000,000 |
1,778,000,000 |
11,937,000,000 |
6,596,000,000 |
5,290,000,000 |
464,000,000 |
1,108,000,000 |
464,000,000 |
4,239,000,000 |
329,000,000 |
275,000,000 |
- |
Update: 2019-06-09 17:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2018-12-31 |
1,839,000,000 |
1,839,000,000 |
1,235,000,000 |
604,000,000 |
380,000,000 |
224,000,000 |
127,000,000 |
1,390,000,000 |
11,003,000,000 |
5,736,000,000 |
5,216,000,000 |
135,000,000 |
464,000,000 |
135,000,000 |
3,893,000,000 |
-128,000,000 |
295,000,000 |
- |
2018-09-30 |
1,889,000,000 |
1,889,000,000 |
1,222,000,000 |
667,000,000 |
363,000,000 |
304,000,000 |
213,000,000 |
1,603,000,000 |
10,986,000,000 |
5,621,000,000 |
5,317,000,000 |
263,000,000 |
304,000,000 |
263,000,000 |
3,698,000,000 |
131,000,000 |
402,000,000 |
- |
2018-06-30 |
1,919,000,000 |
1,919,000,000 |
1,243,000,000 |
676,000,000 |
371,000,000 |
305,000,000 |
219,000,000 |
1,415,000,000 |
10,747,000,000 |
5,484,000,000 |
5,223,000,000 |
132,000,000 |
305,000,000 |
132,000,000 |
3,713,000,000 |
8,000,000 |
323,000,000 |
- |
2018-03-31 |
1,884,000,000 |
1,884,000,000 |
1,226,000,000 |
658,000,000 |
386,000,000 |
272,000,000 |
177,000,000 |
1,371,000,000 |
10,695,000,000 |
5,629,000,000 |
5,030,000,000 |
124,000,000 |
141,000,000 |
124,000,000 |
3,859,000,000 |
-13,000,000 |
180,000,000 |
- |
Update: 2019-06-09 17:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2017-12-31 |
2,172,000,000 |
2,172,000,000 |
1,194,000,000 |
978,000,000 |
709,000,000 |
269,000,000 |
254,000,000 |
1,306,000,000 |
10,503,000,000 |
5,548,000,000 |
4,921,000,000 |
137,000,000 |
36,000,000 |
137,000,000 |
3,784,000,000 |
-188,000,000 |
323,000,000 |
- |